Staying ahead of pharma supply challenges rests on anticipatory pillars and does not require reinventing the wheel, says ...

Merck's CEO Rob Davis emphasizes DEI as a strategic imperative, aligning it with scientific rigor and innovation, showcasing ...

A federal judge has referred plaintiffs’ firm Hagens Berman Sobol Shapiro LLP to the Department of Justice (DOJ) for review of possible unlawful conduct in a pharmaceutical injury case. A ...

As Sandoz looks to address the “biosimilar void” created by the scores of lucrative drugs going off patent in the next decade ...

AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional ...

In an interview with BioPharma Dive, the veteran biotech CEO said there remains a “significant opportunity” for young ...

Berger has participated in meetings (lectures, advisory boards, consultations) sponsored and compensated by pharmaceutical ...

After a newborn died of opioid poisoning, a new branch of pediatrics came into being. But the evidence doesn’t add up.

Last week was a hellscape for vaccines, with a RICO lawsuit against the AAP and the newly antivax CDC coming for your HPV and polio vaccines.

The conservative political analyst Yuval Levin gives Ezra Klein his review of Trump’s first year back in office.